Equities

American Shared Hospital Services

  • Add to watchlist
  • Add to portfolio
  • Add an alert

American Shared Hospital Services

Actions
Health CareMedical Equipment and Services
  • Price (USD)2.25
  • Today's Change-0.02 / -0.88%
  • Shares traded5.99k
  • 1 Year change-26.95%
  • Beta0.1147
Data delayed at least 15 minutes, as of Feb 13 2026 21:00 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

American Shared Hospital Services is a provider of turn-key technology solutions for stereotactic radiosurgery and advanced radiation therapy equipment and services. Its segments include Leasing and Retail. The Leasing segment comprises the Company’s medical equipment leasing. The Retail segment comprises facilities in Peru and Ecuador. Its Proton Beam Radiation Therapy Operations is an alternative to traditional external beam, photon-based radiation delivered by linear accelerators. Its Gamma Knife stereotactic radiosurgery, a non-invasive procedure, is an alternative to conventional brain surgery and/or radiation therapy. The Gamma Knife treats selected malignant and benign brain tumors, arteriovenous malformations, and functional disorders including trigeminal neuralgia (facial pain). It can be an adjunct to conventional brain surgery, radiation therapy, or chemotherapy. The Company provides radiation therapy services both domestically and internationally.

  • Revenue in USD (TTM)29.42m
  • Net income in USD-2.25m
  • Incorporated1983
  • Employees81.00
  • Location
    American Shared Hospital Services601 Montgomery Street, Suite 1112SAN FRANCISCO 94111United StatesUSA
  • Phone+1 (415) 788-5300
  • Fax+1 (415) 788-5660
  • Websitehttps://ashs.com/
More ▼

Institutional shareholders

12.72%Per cent of shares held by top holders
HolderShares% Held
Dimensional Fund Advisors LPas of 31 Dec 2025204.63k3.12%
Corient Private Wealth LLCas of 30 Sep 2025160.56k2.45%
The Vanguard Group, Inc.as of 31 Dec 2025153.74k2.34%
Bridgeway Capital Management LLCas of 30 Sep 202596.69k1.47%
DRW Securities LLCas of 31 Dec 202550.48k0.77%
Renaissance Technologies LLCas of 31 Dec 202549.40k0.75%
Geode Capital Management LLCas of 31 Dec 202532.67k0.50%
NewEdge Advisors LLCas of 30 Sep 202529.73k0.45%
James Investment Research, Inc.as of 31 Dec 202529.73k0.45%
Vanguard Fiduciary Trust Co.as of 31 Dec 202527.41k0.42%
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.